Biological Information

Background Information:

Quickly profile key compound in vitro properties essential for selecting candidates with desirable pharmacokinetic (PK) profiles in later stages of drug development with our Tier 1 ADME Panel. The Eurofins Tier 1 ADME panel consists of 8 ADME assays used to determine compound solubility, permeability, protein binding, intrinsic clearance, and lipophilicity, typically run in early drug discovery to prioritize and select compounds with desirable PK properties needed to progress compounds further into development.

No. of Assays on Panel:

8

Assays on Panel:

Family

Name

Item

2061

Protein

Organism

Assay Sub Type

Family

Name

Item

2062

Protein

Organism

Assay Sub Type

Family

Name

Item

2194

Protein

Organism

Human

Assay Sub Type

Family

Name

Item

3318

Protein

Organism

Human

Assay Sub Type

Cell Based

Family

Name

Item

3320

Protein

Organism

Human

Assay Sub Type

Cell Based

Family

Name

Item

417

Protein

Organism

Assay Sub Type

Family

Name

Item

435

Protein

Organism

Assay Sub Type

Family

Name

Item

607

Protein

Organism

Human

Assay Sub Type

Enzymatic

Testing Information

Test Sample Requirements:

Minimum for 1) Screen: 200 uL of 10 mM DMSO or 2-3 mg of material.

Turnaround Time

Standard:

10 Business Days

Additional Information

Testing Location:

USA - St Charles, MO

Other Information:

Tier 1 ADME Panel Testing Concentrations for Individual Assays; 1) Aqueous solubility assays, ITEM# 2061, 2062, and 435, tested at 1 conc. of 200 uM and 2 replicates, 2) Protein binding assay, ITEM# 2194, tested at 1 conc. of 10 uM and 2 replicates, 3) Caco-2 Permeability assays, ITEM# 3318 and 3320, tested at 1 conc. of 10 uM and 2 replicates, 4) Intrinsic Clearance assay, ITEM# 607, tested at 1 conc. of 0.1 uM and 2 replicates, and 5) Partition Coefficient assay, ITEM# 417, tested at 1 conc. of 100 uM and 3 replicates